Maher N G, Solinas A, Scolyer R A, Puig S, Pellacani G, Guitera P
Melanoma Institute Australia, Sydney, NSW, Australia.
The University of Sydney, Sydney, NSW, Australia.
J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2016-2024. doi: 10.1111/jdv.14381. Epub 2017 Jul 3.
Desmoplastic melanoma (DM) is frequently misdiagnosed clinically and often associated with melanoma in situ (MIS).
To improve the detection of DM using dermoscopy and reflectance confocal microscopy (RCM).
A descriptive analysis of DM dermoscopy features and a case-control study within a melanoma population for RCM feature evaluation was performed blindly, using data obtained between 2005 and 2015. After retrospectively identifying all DM cases with RCM data over the study period (n = 16), a control group of non-DM melanoma patients with RCM data, in a ratio of at least 3 : 1, was selected. The control group was matched by age and primary tumour site location, divided into non-DM invasive melanomas (n = 27) and MIS (n = 27). Invasive melanomas were selected according to the melanoma subtypes associated with the DM cases. The main outcomes were the frequency of melanoma-specific features on dermoscopy for DM; and the odds ratios of RCM features to distinguish DM from MIS and/or other invasive melanomas; or MIS from the combined invasive melanoma group.
At least one of the 14 melanoma-specific features evaluated on dermoscopy was found in 100% of DMs (n = 15 DM with dermoscopy). Known RCM melanoma predictors were commonly found in the DMs, such as pagetoid cells (100%) and cell atypia (100%). The RCM feature of spindle cells in the superficial dermis was more common in DM compared with the entire melanoma control group (OR 3.82, 95% CI 1.01-14.90), and particularly compared to MIS (OR 5.48, 95% CI 1.11-32.36). Nucleated cells in the dermis and the RCM correlate of dermal inflammation were also significant RCM features favouring DM over MIS, as well as invasive melanoma over MIS.
Dermoscopy and RCM may be useful tools for the identification of DM. Certain RCM features may help distinguish DM from MIS and other invasive melanomas. Larger studies are warranted.
促纤维增生性黑色素瘤(DM)在临床上常被误诊,且常与原位黑色素瘤(MIS)相关。
利用皮肤镜检查和反射式共聚焦显微镜(RCM)提高对DM的检测。
对DM的皮肤镜特征进行描述性分析,并在黑色素瘤患者群体中进行病例对照研究以评估RCM特征,研究使用2005年至2015年期间获得的数据。在回顾性确定研究期间所有有RCM数据的DM病例(n = 16)后,选择一组有RCM数据的非DM黑色素瘤患者作为对照组,比例至少为3:1。对照组按年龄和原发肿瘤部位进行匹配,分为非DM浸润性黑色素瘤(n = 27)和MIS(n = 27)。根据与DM病例相关的黑色素瘤亚型选择浸润性黑色素瘤。主要结果是DM在皮肤镜检查中黑色素瘤特异性特征的出现频率;以及RCM特征区分DM与MIS和/或其他浸润性黑色素瘤的优势比;或区分MIS与合并的浸润性黑色素瘤组的优势比。
在接受皮肤镜检查的15例DM中,100%的病例在评估的14种黑色素瘤特异性特征中至少发现一种。已知的RCM黑色素瘤预测指标在DM中普遍存在,如派杰样细胞(100%)和细胞异型性(100%)。与整个黑色素瘤对照组相比,DM中真皮浅层梭形细胞的RCM特征更为常见(优势比3.82,95%置信区间1.01 - 14.90),与MIS相比尤其如此(优势比5.48,95%置信区间1.11 - 32.36)。真皮中的有核细胞以及真皮炎症的RCM相关特征也是有利于DM而非MIS的显著RCM特征,同样有利于浸润性黑色素瘤而非MIS。
皮肤镜检查和RCM可能是识别DM的有用工具。某些RCM特征可能有助于区分DM与MIS和其他浸润性黑色素瘤。有必要进行更大规模的研究。